Breaking News

Formex Names Scientific Advisor

August 14, 2014

McCarty brings 30 years of drug development experience

John McCarty has been named scientific advisor at Formex LLC, and a science advisory board member. Mr. McCarty has more than 30 years of experience in drug product development in the pharmaceutical and biotechnology industries, with expertise in the development of all major dosage forms, and is an inventor on 17 patents. 
 
Mr. McCarty previously held several senior management positions in R&D at Key Pharmaceuticals, Schering–Plough, and Pharmavene (acquired by Shire) and also served as vice president of formulation development at Azo Pharma.
 
"John brings a wealth of knowledge and expertise in formulation development, operations, and manufacturing for both clinical and commercial products to Formex.  We are extremely pleased to work with John as our Senior Consultant and Member of our Scientific Advisory Board," said Dr. J. Blair West, chief scientific officer of Formex. "John is well prepared to contribute to Formex as we continue to grow and expand in our capabilities and market presence."
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer